Publications

Researched and Curated by Clinical and Scientific Experts.

Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.

Not all reports are available for public preview. For more information, please contact us.

Betibeglogene Autotemcel for Beta Thalassemia

Betibeglogene autotemcel (beti-cel; brand name Zynteglo outside U.S.; formerly Lentiviral Autologous Beta-Globin Gene Therapy, LentiGlobin) aims to reduce or eliminate the need for regular blood transfusions in patients with transfusion-dependent beta thalassemia by replacing the faulty HBB gene in the patient’s DNA with a healthier copy of the …

read more

Anumana Artificial Intelligence (AI)-based Electrocardiography (ECG) Algorithm for Detection of Low Left Ventricular Ejection Fraction (LVEF)

The Anumana artificial intelligence (AI)-based electrocardiography (ECG) algorithm analyzes 12-lead ECG data to detect low left ventricular ejection fraction (LVEF), and is proposed for detection of asymptomatic left ventricular systolic dysfunction (ALVSD) in adult patients in the primary care/outpatient setting.

read more